IBI Ag
IBI Ag is developing bioinsecticides with a lower ecological footprint using single domain antibody technology adapted from pharma. Their solutions target a broad spectrum of insects while minimizing impact on non-targeted organisms. The company aims to provide farmers with sustainable and effective crop protection solutions.
Funding Round: Series A
Funding Amount: $6.1M
Date: 13-Feb-2025
Investors: Corteva, Inc., The Trendlines Group, Iron Nation, Consensus Business Group, Israel Innovation Authority
Markets: Agri-biotech, Biotechnology
HQ: Ness Ziona, Israel
Founded: 2017
Website: https://www.ibi-ag.com/
LinkedIn: https://www.linkedin.com/company/ibi-ag
Crunchbase: https://www.crunchbase.com/organization/ibi-ag
Leave a Comment
Comments
No comments yet.